Jean Trédaniel

7.4k total citations
109 papers, 2.6k citations indexed

About

Jean Trédaniel is a scholar working on Oncology, Pulmonary and Respiratory Medicine and Surgery. According to data from OpenAlex, Jean Trédaniel has authored 109 papers receiving a total of 2.6k indexed citations (citations by other indexed papers that have themselves been cited), including 61 papers in Oncology, 58 papers in Pulmonary and Respiratory Medicine and 18 papers in Surgery. Recurrent topics in Jean Trédaniel's work include Lung Cancer Treatments and Mutations (32 papers), Lung Cancer Diagnosis and Treatment (25 papers) and Lung Cancer Research Studies (20 papers). Jean Trédaniel is often cited by papers focused on Lung Cancer Treatments and Mutations (32 papers), Lung Cancer Diagnosis and Treatment (25 papers) and Lung Cancer Research Studies (20 papers). Jean Trédaniel collaborates with scholars based in France, Switzerland and Italy. Jean Trédaniel's co-authors include Paolo Boffetta, Albert Hirsch, Gérard Zalcman, Rodolfo Saracci, Thierry Soussi, Richard Lubin, A Hirsch, Eva Buiatti, Antonio Greco and Zherui Wu and has published in prestigious journals such as Nature Medicine, Journal of Clinical Oncology and Environmental Health Perspectives.

In The Last Decade

Jean Trédaniel

100 papers receiving 2.5k citations

Peers

Countries citing papers authored by Jean Trédaniel

Since Specialization

Citations

This map shows the geographic impact of Jean Trédaniel's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Jean Trédaniel with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Jean Trédaniel more than expected).

Fields of papers citing papers by Jean Trédaniel

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Jean Trédaniel. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Jean Trédaniel. The network helps show where Jean Trédaniel may publish in the future.

Co-authorship network of co-authors of Jean Trédaniel

This figure shows the co-authorship network connecting the top 25 collaborators of Jean Trédaniel. A scholar is included among the top collaborators of Jean Trédaniel based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Jean Trédaniel. Jean Trédaniel is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

#	Work	Indexed citations
1	Sleep Traits, Night Shift Work and Lung Cancer Risk among Women: Results from a Population-Based Case-Control Study in France (The WELCA Study) 2022 ·International Journal of Environmental Research and Public Health ·Emilie Cordina‐Duverger, (unknown), (unknown), (unknown), Diane P. Martin, Jean Trédaniel, Marie Wislez, Hélène Blons, Pierre Laurent‐Puig, Martine Antoine, Pascal Guénel, Loredana Radoï, (unknown)	14
2	Does Very Poor Performance Status Systematically Preclude Single Agent Anti-PD-1 Immunotherapy? A Multicenter Study of 35 Consecutive Patients 2021 ·Cancers ·V. Gounant, M. Duruisseaux, (unknown), (unknown), Olivier Bylicki, Jacques Cadranel, Marie Wislez, Jean Trédaniel, Jean‐Philippe Spano, Carole Hélissey, C. Chouaïd, Olivier Molinier, X. Dhalluin, Ludovic Doucet, J. Hureaux, Aurélie Cazes, Gérard Zalcman	9
3	Risk of lung cancer among women in relation to lifetime history of tobacco smoking: a population-based case-control study in France (the WELCA study) 2021 ·BMC Cancer ·(unknown), (unknown), Diane P. Martin, (unknown), Sylvie Cénée, Martine Antoine, Hélène Blons, Pierre Laurent‐Puig, Jean Trédaniel, Marie Wislez, Isabelle Stücker, Pascal Guénel, Loredana Radoï	10
4	Chemoradiotherapy efficacy is predicted by intra-tumour CD8+/FoxP3+ double positive T cell density in locally advanced N2 non–small-cell lung carcinoma 2020 ·European Journal of Cancer ·(unknown), (unknown), Audrey Mansuet‐Lupo, Laure Gibault, Hélène Blons, Ludovic Fournel, (unknown), Isabelle Cremer, Marie Wislez, Véronique Duchatelle, Jean Trédaniel, Scott A. Hammond, Roy S. Herbst, Marco Alifano, P. Giraud, Diane Damotte	16
5	Efficacy of next treatment received after nivolumab progression in patients with advanced nonsmall cell lung cancer 2018 ·ERJ Open Research ·Adrien Costantini, Jennifer Corny, Vincent Fallet, Sophie Renet, S. Friard, C. Chouaïd, Boris Duchemann, Etienne Giroux‐Leprieur, Laurent Taillade, Ludovic Doucet, (unknown), Stéphane Jouveshomme, Marie Wislez, Jean Trédaniel, Jacques Cadranel	22
6	Modulation of lung cancer cell plasticity and heterogeneity with the restoration of cisplatin sensitivity by neurotensin antibody 2018 ·Cancer Letters ·Zherui Wu, Ludovic Fournel, (unknown), Jin Liu, Agnès Boullier, Nadia Hoyeau, Jean François Fléjou, (unknown), (unknown), Mikaël Agopiantz, E. Segal, Anne Gompel, Marco Alifano, Olle Melander, Jean Trédaniel, Patricia Forgez	16
7	Women Epidemiology Lung Cancer (WELCA) study: reproductive, hormonal, occupational risk factors and biobank 2017 ·BMC Public Health ·(unknown), Isabelle Stücker, Diane P. Martin, Monica Neri, Pierre Laurent‐Puig, Hélène Blons, Martine Antoine, Anne Guiochon‐Mantel, Sylvie Brailly‐Tabard, Marianne Canonico, Marie Wislez, Jean Trédaniel	9
8	Results of the phase III IFCT-0302 trial assessing minimal versus CT-scan-based follow-up for completely resected non-small cell lung cancer (NSCLC) 2017 ·Annals of Oncology ·Virginie Westeel, Fabrice Barlési, (unknown), J.J. Lafitte, (unknown), Philippe Girard, Jean Trédaniel, Marie Wislez, Patrick Dumont, Élisabeth Quoix, Olivier Raffy, Denis Braun, (unknown), François Goupil, J Hermann, Devin E. Eckhoff, Éric Pichon, (unknown), Franck Morin, Pierre Jean Souquet	25
9	Vemurafenib (VM) in non-melanoma V600 and non-V600 BRAF mutated cancers: first results of the ACSE trial 2016 ·Annals of Oncology ·Jean‐Yves Blay, Julien Mazières, David Pérol, Fabrice Barlési, Denis Moro‐Sibilot, Gilles Quéré, Jean Trédaniel, Xavier Troussard, Sophie Leboulleux, David Malka, Aude Fléchon, Claude Linassier, Isabelle Laure Ray-Coquard, Bertrand Arnulf, Ivan Bièche, G. Ferretti, (unknown), Marta Jimenez, Natalie Hoog-Labouret, Agnès Buzyn	3
10	TEP-TDM pour l’exploration du nodule pulmonaire solitaire : acquis et perspectives 2009 ·Revue des Maladies Respiratoires ·David Groheux, Elif Hindié, Jean Trédaniel, Anne‐Laure Giraudet, F. Vaylet, Nathalie Bérenger, Jean‐Luc Moretti	6
11	Pollution atmosphérique et cancer bronchique : données épidémiologiques 2009 ·Revue des Maladies Respiratoires ·Jean Trédaniel, (unknown), Luís Teixeira, Francesco Savinelli, (unknown), Dominique Gossot, Christophe Hennequin	7
12	Use of Adjuvant Chemotherapy in Non-small Cell Lung Cancer in Routine Practice 2009 ·Journal of Thoracic Oncology ·Christophe Massard, (unknown), Vincent Haddad, Jean‐Pierre Pignon, Philippe Girard, I. Monnet, Jean Trédaniel, Benjamin Besse, Jean‐Charles Soria	13
13	Long-term results of endobronchial brachytherapy: A curative treatment? 2006 ·International Journal of Radiation OncologyBiologyPhysics ·Christophe Hennequin, (unknown), Jean Trédaniel, L. Quéro, (unknown), Gérard Zalcman, C Maylin	29
14	Decision making process in oncology practice: Is the information available and what should it consist of? 2005 ·Critical Reviews in Oncology/Hematology ·Jean Trédaniel, Jean‐Yves Blay, François Goldwasser, Bernard Asselain, Serge Koscielny, (unknown), (unknown), (unknown), Jean-Louis Misset, M. Marty	4
15	Phase II randomised trial comparing docetaxel given every 3 weeks with weekly schedule as second-line therapy in patients with advanced non-small-cell lung cancer (NSCLC) 2004 ·Annals of Oncology ·R. Gervais, A Ducoloné, Jean-Luc Breton, Denis Braun, B Lebeau, F. Vaylet, D. Debieuvre, Jean Louis Pujol, Jean Trédaniel, P. Clouet, Élisabeth Quoix	104
16	Risk of childhood cancer and adult lung cancer after childhood exposure to passive smoke: A meta-analysis. 2000 ·Environmental Health Perspectives ·Paolo Boffetta, Jean Trédaniel, Antonio Greco	141
17	Non-smoker lung cancer deaths attributable to exposure to spouse's environmental tobacco smoke 1997 ·International Journal of Epidemiology ·Jean Trédaniel	26
18	Faut-il reconnaître que le tabagisme passif est cancérogène? 1994 ·Revue des Maladies Respiratoires ·Jean Trédaniel, Paolo Boffetta, Alexander W. Hirsch	1
19	Analyses of p53 antibodies in sera of patients with lung carcinoma define immunodominant regions in the p53 protein 1994 ·British Journal of Cancer ·Beata Schlichtholz, Jean Trédaniel, Richard Lubin, Gérard Zalcman, A Hirsch, Thierry Soussi	128
20	The significance of a residual mediastinal mass following treatment for aggressive non-Hodgkin's lymphomas 1992 ·European Respiratory Journal ·Jean Trédaniel, Pauline Brice, Éric Lepage, (unknown), Marolleau Jp, Christophe Fermé, C. Hennequin, JP Fermand, J Frija, Christian Gisselbrecht, al et	6

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact